Decade-Long Profile of Imaging Biomarker Use in Ophthalmic Clinical Trials.
暂无分享,去创建一个
Pedram Hamrah | Felipe A Medeiros | Paolo Nucci | F. Medeiros | P. Nucci | P. Hamrah | E. Villani | Edoardo Villani | Domenico Massaro | Matteo Scaramuzzi | Matteo Scaramuzzi | D. Massaro | Domenico Massaro
[1] Philip J. Rosenfeld,et al. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration , 2016, Investigative ophthalmology & visual science.
[2] Eric Swanson,et al. The Development, Commercialization, and Impact of Optical Coherence Tomography , 2016, Investigative ophthalmology & visual science.
[3] R. Califf,et al. Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions. , 2016, JAMA.
[4] U. Schmidt-Erfurth,et al. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. , 2015, American journal of ophthalmology.
[5] S. Pocock,et al. The perils of surrogate endpoints. , 2015, European heart journal.
[6] J. Wagner,et al. Measuring Biomarker Progress , 2015, Clinical pharmacology and therapeutics.
[7] S. Amur,et al. Biomarker Qualification: Toward a Multiple Stakeholder Framework for Biomarker Development, Regulatory Acceptance, and Utilization , 2015, Clinical pharmacology and therapeutics.
[8] David A Mankoff,et al. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy. , 2015, JAMA oncology.
[9] David A Mankoff,et al. How Imaging Can Impact Clinical Trial Design: Molecular Imaging as a Biomarker for Targeted Cancer Therapy , 2015, Cancer journal.
[10] F Eckstein,et al. Imaging of cartilage and bone: promises and pitfalls in clinical trials of osteoarthritis. , 2014, Osteoarthritis and cartilage.
[11] R. Agha,et al. The reporting quality of parallel randomised controlled trials in ophthalmic surgery in 2011: a systematic review , 2014, Eye.
[12] Felipe A Medeiros,et al. Biomarkers and surrogate endpoints in glaucoma clinical trials , 2014, British Journal of Ophthalmology.
[13] P. Patel,et al. Ophthalmic imaging. , 2014, British medical bulletin.
[14] David Moher,et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. , 2012, The Cochrane database of systematic reviews.
[15] A. Alm,et al. Five-year, Multicenter Safety Study of Fixed-combination Latanoprost/Timolol (Xalacom) for Open-angle Glaucoma and Ocular Hypertension , 2011, Journal of glaucoma.
[16] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.
[17] H. Ahmadieh,et al. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1) , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[18] D. Moher,et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2011, BMJ : British Medical Journal.
[19] R. Danis. The clinical site-reading center partnership in clinical trials. , 2009, American journal of ophthalmology.
[20] Imaging outcomes in cardiovascular clinical trials , 2009, Nature Reviews Cardiology.
[21] J. Tyson,et al. Clinical research methodology I: introduction to randomized trials. , 2008, Journal of the American College of Surgeons.
[22] G. Leung,et al. Quality of Reporting of Key Methodological Items of Randomized Controlled Trials in Clinical Ophthalmic Journals , 2007, Ophthalmic epidemiology.
[23] Viswanath Devanarayan,et al. Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement , 2006, Pharmaceutical Research.
[24] J. Ioannidis. Why Most Published Research Findings Are False , 2005, PLoS medicine.
[25] Stacey L Knobler,et al. The Critical Path to New Medical Products , 2005 .
[26] D. DeMets,et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.